◆ Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2026-09-25
Glecaprevir/Pibrentasvir Concentrations in the Breastmilk of Lactating Women.
L Madeline McCrary, Hideji Fujiwara, John Robinson, Jeannie Kelly, Megan R Curtis, Michael J Durkin, Tracey Habrock-Bach, Jeffrey P Henderson, Laura R Marks
原始摘要（英文原文）· Original abstract
In this prospective pharmacokinetic study of women undergoing chronic hepatitis C virus treatment with glecaprevir/pibrentasvir, the mean glecaprevir and pibrentasvir concentrations in breastmilk were 0.63% and 4.23% of maternal plasma concentrations, with a mean relative infant dose of 0.02% and 0.06%, respectively.